Global Transdermal Patch Market Size, Manufacturers, Opportunities and Forecast to 2030
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
According to APO Research, The global Transdermal Patch market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
According to APO Research, The global Transdermal Patch market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grьnenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- Rx Channel
- OTC Channel
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Patch Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Transdermal Patch Sales Estimates and Forecasts (2019-2030)
1.3 Transdermal Patch Market by Type
1.3.1 Methyl Salicylate-based Patch
1.3.2 Rivastigmine Transdermal Patch
1.3.3 Fentanyl Transdermal Patch
1.3.4 Lidocaine Patch
1.3.5 Diclofenac Patch
1.3.6 Nicotine Transdermal Patch
1.3.7 Others
1.4 Global Transdermal Patch Market Size by Type
1.4.1 Global Transdermal Patch Market Size Overview by Type (2019-2030)
1.4.2 Global Transdermal Patch Historic Market Size Review by Type (2019-2024)
1.4.3 Global Transdermal Patch Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.2 Europe Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Transdermal Patch Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Transdermal Patch Revenue (2019-2024)
3.2 Global Top Players by Transdermal Patch Sales (2019-2024)
3.3 Global Top Players by Transdermal Patch Price (2019-2024)
3.4 Global Transdermal Patch Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Transdermal Patch Key Company Manufacturing Sites & Headquarters
3.6 Global Transdermal Patch Company, Product Type & Application
3.7 Global Transdermal Patch Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transdermal Patch Players Market Share by Revenue in 2023
3.8.3 2023 Transdermal Patch Tier 1, Tier 2, and Tier
4 TRANSDERMAL PATCH REGIONAL STATUS AND OUTLOOK
4.1 Global Transdermal Patch Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Transdermal Patch Historic Market Size by Region
4.2.1 Global Transdermal Patch Sales in Volume by Region (2019-2024)
4.2.2 Global Transdermal Patch Sales in Value by Region (2019-2024)
4.2.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Transdermal Patch Forecasted Market Size by Region
4.3.1 Global Transdermal Patch Sales in Volume by Region (2025-2030)
4.3.2 Global Transdermal Patch Sales in Value by Region (2025-2030)
4.3.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 TRANSDERMAL PATCH BY APPLICATION
5.1 Transdermal Patch Market by Application
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Patch Market Size by Application
5.2.1 Global Transdermal Patch Market Size Overview by Application (2019-2030)
5.2.2 Global Transdermal Patch Historic Market Size Review by Application (2019-2024)
5.2.3 Global Transdermal Patch Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.2 Europe Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Transdermal Patch Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Comapny Information
6.1.2 Hisamitsu Pharmaceutical Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Comapny Information
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments
6.3 Novartis
6.3.1 Novartis Comapny Information
6.3.2 Novartis Business Overview
6.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments
6.4 UCB Pharma
6.4.1 UCB Pharma Comapny Information
6.4.2 UCB Pharma Business Overview
6.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB Pharma Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments
6.5 Mylan
6.5.1 Mylan Comapny Information
6.5.2 Mylan Business Overview
6.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Comapny Information
6.6.2 Teva Pharmaceutical Business Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments
6.7 Nitto Denko
6.7.1 Nitto Denko Comapny Information
6.7.2 Nitto Denko Business Overview
6.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Nitto Denko Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments
6.8 Grьnenthal
6.8.1 Grьnenthal Comapny Information
6.8.2 Grьnenthal Business Overview
6.8.3 Grьnenthal Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Grьnenthal Transdermal Patch Product Portfolio
6.8.5 Grьnenthal Recent Developments
6.9 IBSA Group
6.9.1 IBSA Group Comapny Information
6.9.2 IBSA Group Business Overview
6.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.9.4 IBSA Group Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments
6.10 GSK
6.10.1 GSK Comapny Information
6.10.2 GSK Business Overview
6.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Comapny Information
6.11.2 Luye Pharma Group Business Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments
6.12 Pfizer
6.12.1 Pfizer Comapny Information
6.12.2 Pfizer Business Overview
6.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Pfizer Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments
6.13 Chattem
6.13.1 Chattem Comapny Information
6.13.2 Chattem Business Overview
6.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chattem Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Comapny Information
6.14.2 Dr Reddy’s Laboratories Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments
6.15 Bayer
6.15.1 Bayer Comapny Information
6.15.2 Bayer Business Overview
6.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bayer Transdermal Patch Product Portfolio
6.15.5 Bayer Recent Developments
6.16 Mundipharma
6.16.1 Mundipharma Comapny Information
6.16.2 Mundipharma Business Overview
6.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Mundipharma Transdermal Patch Product Portfolio
6.16.5 Mundipharma Recent Developments
6.17 Endo International
6.17.1 Endo International Comapny Information
6.17.2 Endo International Business Overview
6.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Endo International Transdermal Patch Product Portfolio
6.17.5 Endo International Recent Developments
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Comapny Information
6.18.2 Beijing Tide Pharmaceutical Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Transdermal Patch Sales by Country
7.1.1 North America Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Transdermal Patch Sales by Country (2019-2024)
7.1.3 North America Transdermal Patch Sales Forecast by Country (2025-2030)
7.2 North America Transdermal Patch Market Size by Country
7.2.1 North America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Transdermal Patch Market Size by Country (2019-2024)
7.2.3 North America Transdermal Patch Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Transdermal Patch Sales by Country
8.1.1 Europe Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Transdermal Patch Sales by Country (2019-2024)
8.1.3 Europe Transdermal Patch Sales Forecast by Country (2025-2030)
8.2 Europe Transdermal Patch Market Size by Country
8.2.1 Europe Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Transdermal Patch Market Size by Country (2019-2024)
8.2.3 Europe Transdermal Patch Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Transdermal Patch Sales by Country
9.1.1 Asia-Pacific Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Transdermal Patch Sales by Country (2019-2024)
9.1.3 Asia-Pacific Transdermal Patch Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Transdermal Patch Market Size by Country
9.2.1 Asia-Pacific Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Transdermal Patch Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Transdermal Patch Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Transdermal Patch Sales by Country
10.1.1 Latin America Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Transdermal Patch Sales by Country (2019-2024)
10.1.3 Latin America Transdermal Patch Sales Forecast by Country (2025-2030)
10.2 Latin America Transdermal Patch Market Size by Country
10.2.1 Latin America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Transdermal Patch Market Size by Country (2019-2024)
10.2.3 Latin America Transdermal Patch Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Transdermal Patch Sales by Country
11.1.1 Middle East and Africa Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Transdermal Patch Sales by Country (2019-2024)
11.1.3 Middle East and Africa Transdermal Patch Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Transdermal Patch Market Size by Country
11.2.1 Middle East and Africa Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Transdermal Patch Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Transdermal Patch Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Transdermal Patch Value Chain Analysis
12.1.1 Transdermal Patch Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Transdermal Patch Production Mode & Process
12.2 Transdermal Patch Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Transdermal Patch Distributors
12.2.3 Transdermal Patch Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Transdermal Patch Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Transdermal Patch Sales Estimates and Forecasts (2019-2030)
1.3 Transdermal Patch Market by Type
1.3.1 Methyl Salicylate-based Patch
1.3.2 Rivastigmine Transdermal Patch
1.3.3 Fentanyl Transdermal Patch
1.3.4 Lidocaine Patch
1.3.5 Diclofenac Patch
1.3.6 Nicotine Transdermal Patch
1.3.7 Others
1.4 Global Transdermal Patch Market Size by Type
1.4.1 Global Transdermal Patch Market Size Overview by Type (2019-2030)
1.4.2 Global Transdermal Patch Historic Market Size Review by Type (2019-2024)
1.4.3 Global Transdermal Patch Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.2 Europe Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Transdermal Patch Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Transdermal Patch Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Transdermal Patch Industry Trends
2.2 Transdermal Patch Industry Drivers
2.3 Transdermal Patch Industry Opportunities and Challenges
2.4 Transdermal Patch Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Transdermal Patch Revenue (2019-2024)
3.2 Global Top Players by Transdermal Patch Sales (2019-2024)
3.3 Global Top Players by Transdermal Patch Price (2019-2024)
3.4 Global Transdermal Patch Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Transdermal Patch Key Company Manufacturing Sites & Headquarters
3.6 Global Transdermal Patch Company, Product Type & Application
3.7 Global Transdermal Patch Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Transdermal Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Transdermal Patch Players Market Share by Revenue in 2023
3.8.3 2023 Transdermal Patch Tier 1, Tier 2, and Tier
4 TRANSDERMAL PATCH REGIONAL STATUS AND OUTLOOK
4.1 Global Transdermal Patch Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Transdermal Patch Historic Market Size by Region
4.2.1 Global Transdermal Patch Sales in Volume by Region (2019-2024)
4.2.2 Global Transdermal Patch Sales in Value by Region (2019-2024)
4.2.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Transdermal Patch Forecasted Market Size by Region
4.3.1 Global Transdermal Patch Sales in Volume by Region (2025-2030)
4.3.2 Global Transdermal Patch Sales in Value by Region (2025-2030)
4.3.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 TRANSDERMAL PATCH BY APPLICATION
5.1 Transdermal Patch Market by Application
5.1.1 Rx Channel
5.1.2 OTC Channel
5.2 Global Transdermal Patch Market Size by Application
5.2.1 Global Transdermal Patch Market Size Overview by Application (2019-2030)
5.2.2 Global Transdermal Patch Historic Market Size Review by Application (2019-2024)
5.2.3 Global Transdermal Patch Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.2 Europe Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Transdermal Patch Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Transdermal Patch Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Comapny Information
6.1.2 Hisamitsu Pharmaceutical Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Comapny Information
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments
6.3 Novartis
6.3.1 Novartis Comapny Information
6.3.2 Novartis Business Overview
6.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments
6.4 UCB Pharma
6.4.1 UCB Pharma Comapny Information
6.4.2 UCB Pharma Business Overview
6.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB Pharma Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments
6.5 Mylan
6.5.1 Mylan Comapny Information
6.5.2 Mylan Business Overview
6.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Comapny Information
6.6.2 Teva Pharmaceutical Business Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments
6.7 Nitto Denko
6.7.1 Nitto Denko Comapny Information
6.7.2 Nitto Denko Business Overview
6.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Nitto Denko Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments
6.8 Grьnenthal
6.8.1 Grьnenthal Comapny Information
6.8.2 Grьnenthal Business Overview
6.8.3 Grьnenthal Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Grьnenthal Transdermal Patch Product Portfolio
6.8.5 Grьnenthal Recent Developments
6.9 IBSA Group
6.9.1 IBSA Group Comapny Information
6.9.2 IBSA Group Business Overview
6.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.9.4 IBSA Group Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments
6.10 GSK
6.10.1 GSK Comapny Information
6.10.2 GSK Business Overview
6.10.3 GSK Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Comapny Information
6.11.2 Luye Pharma Group Business Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments
6.12 Pfizer
6.12.1 Pfizer Comapny Information
6.12.2 Pfizer Business Overview
6.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Pfizer Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments
6.13 Chattem
6.13.1 Chattem Comapny Information
6.13.2 Chattem Business Overview
6.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chattem Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments
6.14 Dr Reddy’s Laboratories
6.14.1 Dr Reddy’s Laboratories Comapny Information
6.14.2 Dr Reddy’s Laboratories Business Overview
6.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
6.14.5 Dr Reddy’s Laboratories Recent Developments
6.15 Bayer
6.15.1 Bayer Comapny Information
6.15.2 Bayer Business Overview
6.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bayer Transdermal Patch Product Portfolio
6.15.5 Bayer Recent Developments
6.16 Mundipharma
6.16.1 Mundipharma Comapny Information
6.16.2 Mundipharma Business Overview
6.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Mundipharma Transdermal Patch Product Portfolio
6.16.5 Mundipharma Recent Developments
6.17 Endo International
6.17.1 Endo International Comapny Information
6.17.2 Endo International Business Overview
6.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Endo International Transdermal Patch Product Portfolio
6.17.5 Endo International Recent Developments
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Comapny Information
6.18.2 Beijing Tide Pharmaceutical Business Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
6.18.5 Beijing Tide Pharmaceutical Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Transdermal Patch Sales by Country
7.1.1 North America Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Transdermal Patch Sales by Country (2019-2024)
7.1.3 North America Transdermal Patch Sales Forecast by Country (2025-2030)
7.2 North America Transdermal Patch Market Size by Country
7.2.1 North America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Transdermal Patch Market Size by Country (2019-2024)
7.2.3 North America Transdermal Patch Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Transdermal Patch Sales by Country
8.1.1 Europe Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Transdermal Patch Sales by Country (2019-2024)
8.1.3 Europe Transdermal Patch Sales Forecast by Country (2025-2030)
8.2 Europe Transdermal Patch Market Size by Country
8.2.1 Europe Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Transdermal Patch Market Size by Country (2019-2024)
8.2.3 Europe Transdermal Patch Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Transdermal Patch Sales by Country
9.1.1 Asia-Pacific Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Transdermal Patch Sales by Country (2019-2024)
9.1.3 Asia-Pacific Transdermal Patch Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Transdermal Patch Market Size by Country
9.2.1 Asia-Pacific Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Transdermal Patch Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Transdermal Patch Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Transdermal Patch Sales by Country
10.1.1 Latin America Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Transdermal Patch Sales by Country (2019-2024)
10.1.3 Latin America Transdermal Patch Sales Forecast by Country (2025-2030)
10.2 Latin America Transdermal Patch Market Size by Country
10.2.1 Latin America Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Transdermal Patch Market Size by Country (2019-2024)
10.2.3 Latin America Transdermal Patch Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Transdermal Patch Sales by Country
11.1.1 Middle East and Africa Transdermal Patch Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Transdermal Patch Sales by Country (2019-2024)
11.1.3 Middle East and Africa Transdermal Patch Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Transdermal Patch Market Size by Country
11.2.1 Middle East and Africa Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Transdermal Patch Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Transdermal Patch Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Transdermal Patch Value Chain Analysis
12.1.1 Transdermal Patch Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Transdermal Patch Production Mode & Process
12.2 Transdermal Patch Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Transdermal Patch Distributors
12.2.3 Transdermal Patch Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
